Skip to main content
logo
Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
6.20
+0.12 (1.97%)
At close: Jan 22, 2026, 4:00 PM EST
6.19
-0.01 (-0.16%)
After-hours: Jan 22, 2026, 4:21 PM EST

Foghorn Therapeutics Revenue

Foghorn Therapeutics had revenue of $8.15M in the quarter ending September 30, 2025, with 4.42% growth. This brings the company's revenue in the last twelve months to $24.52M, down -3.91% year-over-year. In the year 2024, Foghorn Therapeutics had annual revenue of $22.60M, down -33.83%.

Revenue (ttm)
$24.52M
Revenue Growth
-3.91%
P/S Ratio
15.61
Revenue / Employee
$218,911
Employees
112
Market Cap
363.21M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202422.60M-11.55M-33.83%
Dec 31, 202334.16M14.93M77.63%
Dec 31, 202219.23M17.91M1,357.77%
Dec 31, 20211.32M889.00K206.74%
Dec 31, 2020430.00K--
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Puma Biotechnology212.00M
XOMA Royalty47.11M
X4 Pharmaceuticals33.98M
AC Immune5.48M
Allogene Therapeutics22.00K
Revenue Rankings

FHTX News

More News